1
It isn't enough that Biovail bought him his own tropical paradise? Eugene Melnyk has a few thoughts to unleash about the battle for the drug company he founded ...Read the full article
This conversation is closed
- Skip to the latest comment
-
Jim Sst from 700th Mission Cap, Canada writes: Biovail carved out a lucrative niche in the global pharmaceutical market by reformulating drugs to get into patients' bodies faster, often with just one pill a day, rather than several. "Some of these new drug delivery systems are just space age," declares Melnyk.
Incorrect. The entire premise of a "controlled release" or "sustained release" drug is to get into the body slower, so that it doesn't get quickly broken down. This way the drug is continuously available at a stable level for a longer period of time.- Posted 17/10/08 at 11:36 PM EST | Alert an Editor | Link to Comment
Comments are closed
Thanks for your interest in commenting on this article, however we are no longer accepting submissions. If you would like, you may send a letter to the editor.
Report an abusive comment to our editorial staff
Alert us about this comment
Please let us know if this reader’s comment breaks the editor's rules and is obscene, abusive, threatening, unlawful, harassing, defamatory, profane or racially offensive by selecting the appropriate option to describe the problem.
Do not use this to complain about comments that don’t break the rules, for example those comments that you disagree with or contain spelling errors or multiple postings.
